BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Endocrine gland cancer AND ETV4, PEA3, 2118, ENSG00000175832, E1AF, E1A-F, PEAS3
46 results:

  • 1. A senescence restriction point acting on chromatin integrates oncogenic signals.
    Lopes-Paciencia S; Bourdeau V; Rowell MC; Amirimehr D; Guillon J; Kalegari P; Barua A; Quoc-Huy Trinh V; Azzi F; Turcotte S; Serohijos A; Ferbeyre G
    Cell Rep; 2024 Apr; 43(4):114044. PubMed ID: 38568812
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Acetyl-Coenzyme A Synthetase 2 Potentiates Macropinocytosis and Muscle Wasting Through Metabolic Reprogramming in Pancreatic cancer.
    Zhou Z; Ren Y; Yang J; Liu M; Shi X; Luo W; Fung KM; Xu C; Bronze MS; Zhang Y; Houchen CW; Li M
    Gastroenterology; 2022 Nov; 163(5):1281-1293.e1. PubMed ID: 35777482
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Identification of potential plasma protein biomarkers for feline pancreatic carcinoma by liquid chromatography tandem mass spectrometry.
    Nabeta R; Katselis GS; Chumala P; Dickinson R; Fernandez NJ; Meachem MD
    Vet Comp Oncol; 2022 Sep; 20(3):720-731. PubMed ID: 35514180
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Tripartite motif containing 63, regulated by E26 transformation specific variant 4, facilitates the thyroid carcinoma progression and the AKT, p38, and ERK signaling pathways.
    He J; Zhang Y; Yao B; Wang L; Tian Z
    Mol Cell Endocrinol; 2022 Jun; 550():111639. PubMed ID: 35390449
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Papillary thyroid cancer: the value of bilateral diagnostic lymphadenectomy.
    Bhangu JS; Bichler C; Altmeier J; Hargitai L; Selberherr A; Mazal P; Brugger J; Scheuba C; Riss P; Niederle B
    Langenbecks Arch Surg; 2022 Aug; 407(5):2059-2066. PubMed ID: 35301585
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. etv4 promotes pancreatic ductal adenocarcinoma metastasis through activation of the CXCL13/CXCR5 signaling axis.
    Gao X; Jiang M; Chu Y; Han Y; Jin Y; Zhang W; Wang W; Yang S; Li W; Fan A; Cao J; Wang J; Liu H; Fu X; Chen D; Nie Y; Fan D
    Cancer Lett; 2022 Jan; 524():42-56. PubMed ID: 34582976
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. The Knockdown of
    Wang L; Zhang Y; Yang J; Liu L; Yao B; Tian Z; He J
    DNA Cell Biol; 2021 Sep; 40(9):1211-1221. PubMed ID: 34283663
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Circular RNA hsa_circ_0001666 sponges miR‑330‑5p, miR‑193a‑5p and miR‑326, and promotes papillary thyroid carcinoma progression via upregulation of etv4.
    Qi Y; He J; Zhang Y; Wang L; Yu Y; Yao B; Tian Z
    Oncol Rep; 2021 Apr; 45(4):. PubMed ID: 33760216
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Impact of Capicua on Pancreatic cancer Progression.
    Yoshiya S; Itoh S; Yoshizumi T; Yugawa K; Kurihara T; Toshima T; Harada N; Hashisako M; Yonemasu H; Fukuzawa K; Oda Y; Mori M
    Ann Surg Oncol; 2021 Jun; 28(6):3198-3207. PubMed ID: 33216264
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. CRLF1-MYH9 Interaction Regulates Proliferation and Metastasis of Papillary Thyroid Carcinoma Through the ERK/etv4 Axis.
    Yu ST; Sun BH; Ge JN; Shi JL; Zhu MS; Wei ZG; Li TT; Zhang ZC; Chen WS; Lei ST
    Front Endocrinol (Lausanne); 2020; 11():535. PubMed ID: 32982961
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Pancreatic cancer incidence and survival and the role of specialist centres in resection rates in England, 2000 to 2014: A population-based study.
    Exarchakou A; Papacleovoulou G; Rous B; Magadi W; Rachet B; Neoptolemos JP; Coleman MP
    Pancreatology; 2020 Apr; 20(3):454-461. PubMed ID: 32014435
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. MiR-1307 influences the chemotherapeutic sensitivity in ovarian cancer cells through the regulation of the CIC transcriptional repressor.
    Zhou Y; Wang M; Shuang T; Liu Y; Zhang Y; Shi C
    Pathol Res Pract; 2019 Oct; 215(10):152606. PubMed ID: 31500928
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. ARF6 and AMAP1 are major targets of
    Hashimoto S; Furukawa S; Hashimoto A; Tsutaho A; Fukao A; Sakamura Y; Parajuli G; Onodera Y; Otsuka Y; Handa H; Oikawa T; Hata S; Nishikawa Y; Mizukami Y; Kodama Y; Murakami M; Fujiwara T; Hirano S; Sabe H
    Proc Natl Acad Sci U S A; 2019 Aug; 116(35):17450-17459. PubMed ID: 31399545
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Interaction of BRAF-induced ETS factors with mutant TERT promoter in papillary thyroid cancer.
    Song YS; Yoo SK; Kim HH; Jung G; Oh AR; Cha JY; Kim SJ; Cho SW; Lee KE; Seo JS; Park YJ
    Endocr Relat Cancer; 2019 Jun; 26(6):629-641. PubMed ID: 30999281
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. The Transcription Factor ETV5 Mediates BRAFV600E-Induced Proliferation and TWIST1 Expression in Papillary Thyroid cancer Cells.
    Puli OR; Danysh BP; McBeath E; Sinha DK; Hoang NM; Powell RT; Danysh HE; Cabanillas ME; Cote GJ; Hofmann MC
    Neoplasia; 2018 Nov; 20(11):1121-1134. PubMed ID: 30265861
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. etv4 Facilitates Cell-Cycle Progression in Pancreatic Cells through Transcriptional Regulation of Cyclin D1.
    Tyagi N; Deshmukh SK; Srivastava SK; Azim S; Ahmad A; Al-Ghadhban A; Singh AP; Carter JE; Wang B; Singh S
    Mol Cancer Res; 2018 Feb; 16(2):187-196. PubMed ID: 29117940
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. COMPARING THE ENZYME REPLACEMENT THERAPY COST IN POST PANCREATECTOMY PATIENTS DUE TO PANCREATIC TUMOR AND CHRONIC PANCREATITIS.
    Fragoso AV; Pedroso MR; Herman P; Montagnini AL
    Arq Gastroenterol; 2016; 53(2):94-7. PubMed ID: 27305415
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Sustained, low-dose intraperitoneal cisplatin improves treatment outcome in ovarian cancer mouse models.
    Ye H; Tanenbaum LM; Na YJ; Mantzavinou A; Fulci G; Del Carmen MG; Birrer MJ; Cima MJ
    J Control Release; 2015 Dec; 220(Pt A):358-367. PubMed ID: 26548976
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Systematic transcriptome analysis reveals tumor-specific isoforms for ovarian cancer diagnosis and therapy.
    Barrett CL; DeBoever C; Jepsen K; Saenz CC; Carson DA; Frazer KA
    Proc Natl Acad Sci U S A; 2015 Jun; 112(23):E3050-7. PubMed ID: 26015570
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Results of immunohistochemical staining of cell-cycle regulators: the prediction of recurrence of functioning pituitary adenoma.
    Lee EH; Kim KH; Kwon JH; Kim HD; Kim YZ
    World Neurosurg; 2014; 81(3-4):563-75. PubMed ID: 24067736
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 3.